Victor G Prieto

33PUBLICATIONS

107CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (33)

Sort by Publication Date:

|Jun 05, 2026

Dermatologic Toxicities Associated With Novel Pan-RAS/RAF Inhibitors.

|Jan 18, 2026

Bispecific Dual-Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients.

Niloofar Sina, Fiorinda Muhaj, Volha Lenskaya

|Jul 10, 2025

Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma.

Elizabeth M Burton, Denái R Milton, Michael T Tetzlaff

|May 07, 2025

Upregulation of MMP9 expression in postradiation angiosarcoma of the breast: a possible predictive risk factor.

Qingqing Ding, Phyu P Aung, Hongxia Sun

|Jan 06, 2025

Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes.

Erol Can Bayraktar, Phyu P Aung, Pavandeep Gill

|Nov 12, 2024

Grading Melanocytic Dysplasia: Updated Histopathologic Criteria.

Christopher R Shea, Victor G Prieto, Catherine M Shachaf

Pageof 6

Frequent Collaborators

19 joint publications

Carlos Torres-Cabala

15 joint publications

Jonathan L Curry

15 joint publications

Phyu P Aung

15 joint publications

Priyadharsini Nagarajan

12 joint publications

Woo Cheal Cho

Doina Ivan

Isabella C Glitza

Pavandeep Gill

Hussein Tawbi

Aimi T Rothrock

Frequent Collaborators

19 joint publications

Carlos Torres-Cabala

15 joint publications

Jonathan L Curry

15 joint publications

Phyu P Aung

15 joint publications

Priyadharsini Nagarajan